Choongang Vaccine Laboratories Co., Ltd.(cavac)

Country/Region: South Korea     State/Province: Seoul

Company Introduction
In 1968, the private company which was founded to be base on, Choong Ang Animal Disease Laboratory Co., Ltd founded the research, development, and manufacture of the vaccine for  prevention of animal disease in 1994. In 1994, Choong Ang Animal Disease Laboratory Co., Ltd got KVGMP certificate the industry's first on-time and merged PaCheon Laboratory Co., Ltdto strengthen for research and development in these industries.
In 2003, change the name to Choong Ang Vaccine Laboratories Co., Ltd (CAVAC) and listed stocks to KOSDAQ in October, so CAVAC could be based on growing as the company which equiped a global age international competitive power. CAVAC investes 6~10% in research and development of yearly sale to secure the technical competitiveness against the multinational companies. CAVAC also provides high level solution and product assurance to the consumers through the radical seed lot system and running the modern style animal test laboratories building.
At the end of the September in 2006, CAVAC is based on the best market share company among the domestic animal vaccine companies, it extends the export to Southeast Asia, Middle East area and it also focuses on to China, India and Brazil as like developing countries and emerging markets with the best effort in advance.
Company Overview

Business Type: Manufacturer

Year Established: 2010

Employees: 101-500 People

Plant Area: 30,000-50,000 square meters

Contact Information

Fax: +82-42-863-8454

Business Information

Main Markets: Bangladesh,Indonesia,Pakistan,Thailand,Viet Nam

Trade Capacity: FOB, CFR, CIF, EXW, FAS, CIP, FCA, CPT, DEQ, DDP, DDU, Express Delivery, DAF, DES

Contract Manufacturing: OEM Service Offered, Buyer Label Offered

Nearest Port: Inquire Now

Trade & Financial Information

Annual Revenue: US$50 Million - US$100 Million

Total Revenue: US$1 Million - US$2.5 Million

Export Revenue: US$1 Million - US$2.5 Million

Annual Output: US$50 Million - US$100 Million

Registered Capital: 5000000 RMB

Export Percentage: 91% - 100%

Payment Modes: USD, EUR, JPY, CAD, AUD, HKD, GBP, CNY, CHF

Lead Time: 2-4 days

Import/Export Mode: Have Own Export Lisence

Product Showcase
Health & Beauty
Animal & Veterinary
Veterinary Medicine

CL-Link > Health & Medicines in South Korea Health & Medicines in Seoul Health Care Supplement in South Korea Health Care Supplement in Seoul ceftiofur sodium injection powder in South Korea ceftiofur sodium injection powder in Seoul